Profile | GDS4284 / 231730_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 343.172 | 58 |
GSM687648 | Patient 402 control | 415.008 | 61 |
GSM687653 | Patient 403 control | 245.94 | 53 |
GSM687658 | Patient 404 control | 235.452 | 51 |
GSM687663 | Patient 411 control | 303.397 | 55 |
GSM687668 | Patient 422 control | 330.156 | 57 |
GSM687673 | Patient 424 control | 264.259 | 52 |
GSM687678 | Patient 425 control | 322.881 | 56 |
GSM687683 | Patient 427 control | 268.776 | 52 |
GSM687688 | Patient 428 control | 144.301 | 42 |
GSM687695 | Patient 441 control | 228.016 | 42 |
GSM687699 | Patient 443 control | 266.921 | 51 |
GSM687704 | Patient 444 control | 234.434 | 51 |
GSM687707 | Patient 448 control | 290.848 | 53 |
GSM687712 | Patient 449 control | 394.379 | 60 |
GSM687719 | Patient 450 control | 359.252 | 56 |
GSM687724 | Patient 451 control | 279.265 | 53 |
GSM687728 | Patient 452 control | 272.035 | 53 |
GSM687646 | Patient 401 treated 24h | 405.22 | 60 |
GSM687649 | Patient 402 treated 24h | 427.435 | 61 |
GSM687665 | Patient 411 treated 24h | 233.243 | 49 |
GSM687651 | Patient 402 treated 4 weeks | 374.966 | 58 |
GSM687667 | Patient 411 treated 4 weeks | 353.286 | 58 |
GSM687670 | Patient 422 treated 24h | 352.27 | 57 |
GSM687671 | Patient 422 treated 4 weeks | 380.596 | 59 |
GSM687654 | Patient 403 treated 24h | 253.366 | 54 |
GSM687675 | Patient 424 treated 24h | 305.881 | 54 |
GSM687685 | Patient 427 treated 24h | 243.08 | 52 |
GSM687656 | Patient 403 treated 4 weeks | 313.856 | 57 |
GSM687677 | Patient 424 treated 4 weeks | 230.913 | 51 |
GSM687687 | Patient 427 treated 4 weeks | 324.853 | 57 |
GSM687692 | Patient 428 treated 4h | 258.678 | 53 |
GSM687716 | Patient 449 treated 4h | 363.558 | 59 |
GSM687722 | Patient 450 treated 4h | 331.067 | 55 |
GSM687680 | Patient 425 treated 24h | 332.589 | 57 |
GSM687690 | Patient 428 treated 24h | 264.709 | 54 |
GSM687700 | Patient 443 treated 24h | 244.377 | 45 |
GSM687705 | Patient 444 treated 24h | 269.486 | 55 |
GSM687714 | Patient 449 treated 24h | 469.711 | 63 |
GSM687721 | Patient 450 treated 24h | 321.719 | 54 |
GSM687682 | Patient 425 treated 4 weeks | 292.181 | 56 |
GSM687694 | Patient 428 treated 4 weeks | 191.585 | 49 |
GSM687702 | Patient 443 treated 4 weeks | 268.781 | 52 |
GSM687718 | Patient 449 treated 4 weeks | 351.127 | 59 |
GSM687723 | Patient 450 treated 4 weeks | 379.482 | 59 |
GSM687661 | Patient 404 treated 4h | 340.699 | 57 |
GSM687710 | Patient 448 treated 4h | 283.831 | 55 |
GSM687726 | Patient 451 treated 4h | 246.865 | 50 |
GSM687730 | Patient 452 treated 4h | 14.3434 | 1 |
GSM687660 | Patient 404 treated 24h | 136.62 | 35 |
GSM687697 | Patient 441 treated 24h | 227.059 | 45 |
GSM687709 | Patient 448 treated 24h | 297.448 | 55 |
GSM687725 | Patient 451 treated 24h | 196.779 | 44 |
GSM687729 | Patient 452 treated 24h | 257.404 | 48 |
GSM687727 | Patient 451 treated 4 weeks | 125.441 | 35 |
GSM687731 | Patient 452 treated 4 weeks | 263.102 | 51 |